Yeytuo

Yeytuo (lenacapavir) is an oral antiviral medication used for long-acting HIV treatment and prevention. This prescription drug belongs to the capsid inhibitor class, designed for extended dosing intervals. Suitable for adults and adolescents weighing at least 35 kg. Always consult a healthcare provider before use.

Lenacapavir is used for HIV treatment in combination with other antiretrovirals, particularly for people with limited treatment options. It is also approved for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection in high-risk adults and adolescents. The medication works by blocking HIV replication at the capsid stage, offering a long-acting alternative to daily pills.

Lenacapavir is taken as a once-weekly oral dose for the first two weeks, followed by a maintenance dose every six months. Many users report stable energy levels and no immediate side effects, though some may experience mild gastrointestinal discomfort. The extended dosing schedule aims to improve adherence and convenience compared to daily regimens.

Store lenacapavir at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Discuss your full medical history with a healthcare provider, especially if you have kidney or liver conditions. Do not share this medication with others, even if they have similar symptoms.

Lenacapavir may interact with other medications, including strong CYP3A inducers like rifampin or St. John’s wort, which can reduce its effectiveness. Caution is advised when combining with drugs that affect liver enzymes, such as certain anticonvulsants or antifungals. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using.